首页> 外国专利> Determination of the preformed immune status in the case of active diseases with intracellular causative agents for the reconstruction of infection because

Determination of the preformed immune status in the case of active diseases with intracellular causative agents for the reconstruction of infection because

机译:在活动性疾病中使用细胞内病原体确定感染重建所需的预先免疫状态

摘要

A process for the determination of the preformed immune status in the case of active diseases with intracellular causative agents for the reconstruction of infection because by means of flow cytometry analysis of cytokines,characterized by the,that the origin of an active disease, namely primarily occurrence of an infection, or reactivation, by means of a specific cytokine displacement, comprising the steps of:– Stimulation of heparinised whole blood with the pathogen - specific antigens, with staphylococcus enterotoxin b (seb) as a positive control, as well as with solvent as a negative control with or without the addition of co - stimulatory antibodies anti - cd49d and anti - cd28.– Incubation for 30 min to 4 h hours at 35 to 39°C. and 3 (5) to 10% co2.– The addition of a secretion inhibitor, for example, brefeldin a– It was incubated for 2 to 12 hours at 35 to 39°C. and 3 (5) to 10% co2– Lysis of erythrocytes and fixing of leukocytes– Multiple washing steps for the isolation of the leukocytes– Conveyance of the cell membrane, by means of resistance of the present invention is that by the addition of saponin or another, the cell membrane - permeability which.– Incubation with specific fluorochrome - labelled antibodies against cd4, cd69, ifnγ - γ and il - 2 for at least 10 minutes on ice or at room temperature - or in the case of 35 to 39°C.– Renewed washing steps for the removal of antibodies unbonded– Analysis of the cells to a flow cytometerThe evaluation of the component and / or of the ratio of ifnγ -, il - 2 - or both cytokines producing t - cells for the determination of the infection origin in the sense of a primary infection or a reactivation in patients with an active infection disease.
机译:在活动性疾病中用细胞内病原体来确定感染情况的预先确定的免疫状态的过程,用于通过感染的细胞因子的流式细胞术分析来表征感染,该活动性因子的特征在于活动性疾病的起源即最初发生通过特定的细胞因子置换来进行感染或再激活的方法,包括以下步骤:–用病原体-特定抗原,葡萄球菌肠毒素b(seb)作为阳性对照以及溶剂刺激肝素化全血作为阴性对照,可添加或不添加抗CD49d和抗CD28共刺激抗体。在35至39°C下孵育30分钟至4小时。和3(5)到10%的co 2 。–添加分泌抑制剂,例如布雷菲德菌素a –将其在35至39°C下孵育2至12小时。和3(5)至10%的co 2 至10%–红细胞的溶解和白细胞的固定–用于分离白细胞的多个洗涤步骤–通过本发明的抗性转运细胞膜是通过添加皂苷或其他成分,使细胞膜的通透性降低。–在冰上或室温下,用特异性荧光染料标记的针对cd4,cd69,ifnγ-γ和il-2的抗体孵育至少10分钟-或在35至39°C的情况下–重新进行洗涤步骤以去除未结合的抗体–用流式细胞仪分析细胞对组分和/或ifnγ-,il-2-或两种细胞因子之比的评估从原发感染或活动性感染疾病患者的再激活的意义上讲,产生用于确定感染起源的t细胞。

著录项

  • 公开/公告号DE102013014381A1

    专利类型

  • 公开/公告日2015-03-05

    原文格式PDF

  • 申请/专利权人 RED FLAG DIAGNOSTICS GMBH;

    申请/专利号DE20131014381

  • 发明设计人 GLEICH ANMELDER;

    申请日2013-08-30

  • 分类号G01N33/53;

  • 国家 DE

  • 入库时间 2022-08-21 14:55:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号